BioArctic’s partner Eisai launches Leqembi in South Korea to treat MCI due to AD or mild AD dementia: Stockholm, Sweden Friday, November 29, 2024, 16:00 Hrs [IST] BioArctic ABs ...

A new study from the University of Liverpool significantly advances the understanding of Alzheimer’s disease. Researchers ...

Complex problems often require creative solutions, and the increasing global burden of Alzheimer’s disease certainly ...

A recent study in Nature Neuroscience provides new insights into how amyloid-beta and tau proteins, which accumulate in the ...

Alzheimer’s disease, the most common form of dementia, affects millions of people worldwide, slowly robbing them of their ...

Alector has significant cash reserves but faces high cash burn, with no immediate catalysts and uncertain prospects for its ...

See the new treatment that will break a Pfizer monopoly on a drug for heart disease.

A new study represents a significant step forward in scientists' understanding of Alzheimer's disease. A team of investigators has examined the role of two proteins found in the brain and suggest the ...

Someone with FTD may also notice changes in personality or mood and difficulties with language. Dr. McGrath points out that ...

A potential new treatment for Alzheimer’s disease may come in the form of a nasal spray. Researchers in Italy have discovered ...

A new study from the University of Liverpool represents a significant step forward in scientists' understanding of Alzheimer's disease.

BridgeBio’s Attruby wins approval for transthyretin amyloid cardiomyopathy while the FDA accepts Alnylam’s application for ...